We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2021 19:00 | Extrader, Your comment came across as an attempt to dislodge confidence in the shares, but as you have been called out you have now attempted a somewhat disingenous backtracking. Say what you mean, with confidence, and preferably supportive facts, or don't bother? p.s just 'joking'! or am I? Depends ;) or does it? erm... help!! | king suarez | |
10/1/2021 18:18 | Hi Trader_3, I thought from .."This may be standard gubmint or research dept wording, but hardly inspires confidence .." that my comments would have been interpreted as jocular / 'rolling of eyes' at the lack of 'consistency of message', nothing more. Memo to self : 'must try harder' - 'remember to smile with your eyes as people can't see your masked mouth'. ATB | extrader | |
10/1/2021 17:26 | ExT – talk about looking for problems when there aren’t any! Can I suggest you conduct a small amount of research prior to your post’s. There are a few links below which may assist you, regarding HMG’s 'commitment' to Covid CHIM’s: £33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust. The Human Challenge Programme, part of the government’s Vaccine Taskforce, is a partnership between the government, the NHS, academia and the private sector to establish human challenge studies for COVID-19 in the UK. hxxps://www.openorph UK Vaccine Taskforce 2020 Achievements and Future Strategy ‘Building this world leading, ambitious capability now will enable the UK to optimise and prioritise future pandemic vaccines, generating long term value and pandemic preparedness for the UK for SARS-CoV-2 and beyond - a valuable legacy for the UK.’ HRA Chair statement & Covid CHIM’s hxxps://www.hra.nhs. | trader_3 | |
10/1/2021 15:38 | Hi Trader_3, Thanks for this ! But..... .."with the possibility of extension depending upon availability of funding..." This may be standard gubmint or research dept wording, but hardly inspires confidence (in a job applicant, never mind investor) that HMG (which can fritter £ 12 billion on failed track 'n trace ) is really committed to this area, does it ? Oh, well... ATB | extrader | |
10/1/2021 14:01 | Imperial College London Recruitment for Covid Human Challenge Study Research Technician x2 Job description We are looking for two Research Technicians. This is an exciting opportunity to provide technical support to the internationally recognised research laboratory led by Professor Wendy Barclay. You will support the Barclay research group in carrying out processing and characterisation of samples from a SARS-CoV-2 human challenge study... ...This post is full time and fixed term for 12 months, with the possibility of extension depending upon availability of funding. Seems like the ICL recruitment is ongoing and post holders will be in place for a minimum of twelve months. hxxps://www.mendeley | trader_3 | |
10/1/2021 13:50 | Yeh, seen on the news here about the Nurse on Friday, she also passed it on to a two family members. I guess the big unknown as not tested and signed off as one dose is how long protection takes to build up. But with people now having to wait 12 weeks instead of 21 days could still be a lot of people catching it and spreading it. | sh0wmethemoney | |
10/1/2021 12:31 | Surely we are just the sort of company that is going to be benefit from this :) | jeanesy | |
10/1/2021 11:23 | Good to see new investors here! Welcome! Bodes well for this gem of a company. It's right place right time now. GLA | bobsworth | |
10/1/2021 11:03 | Each to his own! For starting points for research, I use stock screening tools, RNS announcements and companies mentioned in various places (though not just tip sheets). Find that gives me enough starting points | adamb1978 | |
10/1/2021 09:57 | Adam, I'm a new boy here at OO too. I don't subscribe to Techinvest as I consider it too expensive, but I do look at all the free tipsters............ | jansky61 | |
10/1/2021 08:26 | Yes, apologies for that Malcolm - thought that after I posted it. I don't subscribe to these tip sheets as never been convinced by the value of them and prefer to rely on my own research | adamb1978 | |
10/1/2021 07:46 | Adam81978. Try subscribing it's copyright and many subscribers will be buying tipped stocks Monday before the herd. They do think that this industry is ripe for consolidation . | malcolmmm | |
09/1/2021 22:59 | She hadn't had the second dose The nurse received a first dose of the Pfizer/BioNtech in December last year Three weeks later she began suffering Covid-19 symptoms and tested positive Experts have warned that it takes time for immunity to Covid-19 to build up The Pfizer vaccine offers up to 95 percent protection against Covid-19 A nurse in Wales caught coronavirus | malcolmmm | |
09/1/2021 21:36 | What's the other 11 Malcolm?!? | adamb1978 | |
09/1/2021 21:23 | Techinvest out this weekend ORPH is one of their twelve UK new year tips , They also think they will make further acquisitions | malcolmmm | |
09/1/2021 21:09 | No problem, welcome aboard. | gregb | |
09/1/2021 21:05 | Thanks Greg | adamb1978 | |
09/1/2021 20:05 | Just search for Open Orphan on YouTube and sort by date order. There are a couple presentations for December. | gregb | |
09/1/2021 18:59 | Hello I'm new to OPRH but like what I've read up so far - now just need to run the numbers properly. There was a reference a few pages back about a December presentation but the latest on their website is from October. Was there another one at a private event and/or please could someone forward me a link? many thanks Adam | adamb1978 | |
09/1/2021 17:40 | Takes time to build up resistance after the vaccine | molatovkid | |
09/1/2021 16:28 | OO one of Techinvest’s tips for 2021 | talkman2 | |
09/1/2021 16:09 | Interesting looking at the merger of 4D Pharma into a SPAC, they agreed the merger in October 2020 and looks like the merger will happen in Jan 2021. If ORPH put immutex into a SPAC the divi will be in approx. April time at the earliest. | thomas11 | |
09/1/2021 13:14 | That is true. But hard to know whether people had covid before having jab. Dreadful times and very hard to see things getting better in the near future. | mam fach | |
09/1/2021 13:03 | Press stories starting to emerge of people getting Covid after being vaccinated - doesn't come as any great surprise. As question marks/doubts begin to surface, this is likely to put OO more in the spotlight. Great news for us as shareholders imo, but dire from the perspective of this unfolding health crisis. Be safe, be responsible everyone. | felchandbart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions